Tundra Space

Tundra Space

Book DemoDirectoryLog InSign Up

Clinical Research Directory

Browse clinical research sites, groups, and studies.

SitesGroupsStudies
Back to Studies
COMPLETED
NCT03510351

Clinical Outcomes With Ceftolozane-tazobactam for MDR Pseudomonas Infections

Sponsor: Temple University

View on ClinicalTrials.gov

Summary

This study will describe clinical outcomes in patients who received ceftolozane-tazobactam for a Pseudomonas aeruginosa infection. Primary outcomes include 30-day and in-hospital mortality.

Official title: Clinical Outcomes With Ceftolozane-tazobactam in Patients With Multi Drug Resistant (MDR) Pseudomonas Aeruginosa Infections

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

200

Start Date

2017-02-01

Completion Date

2018-02-28

Last Updated

2026-05-22

Healthy Volunteers

No

Conditions

Pseudomonas InfectionsPseudomonas Aeruginosa

Interventions

DRUG

Ceftolozane-Tazobactam

Subjects treated with ceftolozane-tazobactam for Pseudomonas infections

Locations (1)

Temple University, School of Pharmacy

Philadelphia, Pennsylvania, United States